6.70
+0.2(+3.08%)
Currency In EUR
Address
25 Norman Way
Cambridge,
United Kingdom of Great Britain and Northern Ireland
Phone
N/A
Website
Sector
Healthcare
Industry
Biotechnology
Employees
101
First IPO Date
November 23, 2021
| Name | Title | Pay | Year Born |
| Heikki Lanckriet | Chief Executive Officer, Chief Scientific Officer & Executive Director | 599,456 | 1977 |
| Amy Walker | Chief Operating Officer & Director | 350,913 | N/A |
| David Roth | Chief Financial Officer, Company Secretary & Executive Director | 430,397 | 1967 |
| Manja Hermina Elisabeth Maria Boerman | Executive Chair of the Board | 0 | 1966 |
4basebio Plc is a biotechnology company, which engages in the business of developing advanced therapy medicinal products through synthetic DNA products and non-viral, cell targeting nucleic acid delivery platforms. The firm is involved in manufacturing and supplying high quality synthetic DNA products for research, therapeutic, and pharmacological use; and developing target specific non-viral vectors for the efficient delivery of payloads in patients. The company was founded on December 22, 2020 and is headquartered in Cambridge, the United Kingdom.